Medifast (MED) Depreciation and Depletion (2024 - 2026)

Medifast has reported Depreciation and Depletion for 3 years, with the latest figure at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion rose 13.04% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (down 37.93% YoY), and the FY2025 full-year result was $10.5 million, down 39.66% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $2.6 million, roughly flat from $2.6 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $10.5 million in Q2 2024, with the low at $2.3 million in Q1 2024.
• Historically, Depreciation and Depletion has averaged $3.4 million across 3 years, with a median of $2.5 million in 2025.
• The largest YoY upside for Depreciation and Depletion was 13.04% in 2025 against a maximum downside of 70.48% in 2025.
• Medifast's Depreciation and Depletion stood at $2.3 million in 2024, then grew by 13.04% to $2.6 million in 2025, then changed by 0.0% to $2.6 million in 2026.
• The last three Depreciation and Depletion figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.